Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
This piece outlines scenarios where a lifecycle fund may be preferable to a target date fund, helping you tailor your retirement strategy.
23,259 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Meta Platforms faces a crossroads as AI investments collide with rising costs. Analysts see potential upside toward $...
With just four weeks on the Senate calendar before the August recess, the CLARITY Act must clear ethics hurdles and w...
Bitcoin hovers near $70,000 as Iran-driven energy volatility cools and policy expectations shift, setting up a pivota...
Bitcoin remains in a delicate balance, trading around the $62,000s as traders watch a stubborn $63,000 barrier. Analy...
Eric Trump’s American Bitcoin announced a 1-for-15 reverse stock split to protect its Nasdaq listing as its treasury ...
A lifetime income trade-off is unfolding for millions: claiming Social Security at 62, a move dubbed the $600 social ...
A White House meeting with Senate lawmakers failed to finalize ethics language tied to the Digital Asset Market Clari...
ServiceNow is set to report Q2 results after the close as investors weigh growth, margins, and AI monetization progre...
Oil remains a core part of global energy, and a patient, rules-based approach can reward investors. This article buil...
Elite MBA salaries stay sky-high, with three-year post-graduation medians near $260,000 at top schools. The numbers r...
Marc Zeller’s audit of Aave Labs has sparked new tensions in the AaveDAO as supporters and critics spar over a $51 mi...